Evaluation of [11C] laniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in rats G Luurtsema, RC Schuit, RP Klok, J Verbeek, JE Leysen, ... Nuclear medicine and biology 36 (6), 643-649, 2009 | 81 | 2009 |
[11C]phenytoin revisited: synthesis by [11C]CO carbonylation and first evaluation as a P-gp tracer in rats J Verbeek, J Eriksson, S Syvänen, M Labots, ECM de Lange, RA Voskuyl, ... EJNMMI research 2, 1-11, 2012 | 41 | 2012 |
Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C] benzyl]-morpholine: evaluation of a potential PET ligand AJ Airaksinen, JA Jablonowski, M van der Mey, AJ Barbier, RP Klok, ... Nuclear medicine and biology 33 (6), 801-810, 2006 | 40 | 2006 |
Design, Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of Bridgehead Iodinated Analogues of N-{2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl … R Al Hussainy, J Verbeek, D van der Born, AH Braker, JE Leysen, RJ Knol, ... Journal of medicinal chemistry 54 (10), 3480-3491, 2011 | 37 | 2011 |
[11C] quinidine and [11C] laniquidar PET imaging in a chronic rodent epilepsy model: impact of epilepsy and drug-responsiveness S Syvänen, V Russmann, J Verbeek, J Eriksson, M Labots, C Zellinger, ... Nuclear medicine and biology 40 (6), 764-775, 2013 | 31 | 2013 |
Carbon-11 labeled tracers for in vivo imaging of P-glycoprotein function: kinetics, advantages and disadvantages G Luurtsema, J Verbeek, M Lubberink, A A Lammertsma, R Dierckx, ... Current topics in medicinal chemistry 10 (17), 1820-1833, 2010 | 28 | 2010 |
Recent Progress in Metal Catalyzed Direct Carboxylation of Aryl Halides and Pseudo Halides Employing CO2: Opportunities for 11C Radiochemistry M Ahamed, J Verbeek, U Funke, J Lecina, A Verbruggen, G Bormans ChemCatChem 8 (24), 3692-3700, 2016 | 27 | 2016 |
Quantification of dynamic 11C-phenytoin PET studies S Mansor, R Boellaard, FE Froklage, EDM Bakker, M Yaqub, RA Voskuyl, ... Journal of Nuclear Medicine 56 (9), 1372-1377, 2015 | 26 | 2015 |
Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl) piperazin-1-yl] ethyl}-N-(pyridin-2-yl) cyclohexanecarboxamide (WAY … R Al Hussainy, J Verbeek, D van der Born, J Booij, JKDM Herscheid European journal of medicinal chemistry 46 (12), 5728-5735, 2011 | 25 | 2011 |
Synthesis and preclinical evaluation of [11C] D617, a metabolite of (R)-[11C] verapamil J Verbeek, S Syvänen, RC Schuit, J Eriksson, EC de Lange, ... Nuclear medicine and biology 39 (4), 530-539, 2012 | 23 | 2012 |
Development and characterization of [123I] iodotiagabine for in-vivo GABA-transporter imaging O Schijns, M van Kroonenburgh, F Beekman, J Verbeek, J Herscheid, ... Nuclear Medicine Communications 34 (2), 175-179, 2013 | 12 | 2013 |
Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237) JACM Goos, J Verbeek, AA Geldof, AC Hiemstra, MA van de Wiel, ... Nuclear medicine and biology 43 (1), 63-72, 2016 | 11 | 2016 |
Synthesis, biodistribution and PET studies in rats of 18F-Labeled bridgehead fluoromethyl analogues of WAY-100635 R Al Hussainy, J Verbeek, D van der Born, C Molthoff, J Booij, ... Nuclear medicine and biology 39 (7), 1068-1076, 2012 | 10 | 2012 |
Sharing and collecting hospital-based health technology assessment reports internationally: Is an extensive participation of stakeholders realistic? J Verbeek, M Hiligsmann, A Cicchetti, M Marchetti International Journal of Technology Assessment in Health Care 34 (5), 527-534, 2018 | 8 | 2018 |
The binding characteristics and orientation of a novel radioligand with distinct properties at 5-HT3A and 5-HT3AB receptors AJ Thompson, MHP Verheij, J Verbeek, AD Windhorst, IJP de Esch, ... Neuropharmacology 86, 378-388, 2014 | 8 | 2014 |
Synthesis and preliminary preclinical evaluation of fluorine-18 labelled isatin-4-(4-methoxyphenyl)-3-thiosemicarbazone ([18F]4FIMPTC) as a novel PET tracer of P … J Verbeek, J Eriksson, S Syvänen, M Huisman, RC Schuit, CFM Molthoff, ... EJNMMI radiopharmacy and chemistry 3, 1-19, 2018 | 5 | 2018 |
Initial evaluation of P2X (7) R antagonists [C-11] A-740003 and [C-11] SMW64-D16 as PET tracers of microglial activation in neuroinflammation B Janssen, D Ory, SM Wilkinson, DJ Vugts, EJ Kooijman, J Verbeek, ... Journal Of Labelled Compounds & Radiopharmaceuticals 58, S277-S277, 2015 | 5 | 2015 |
[C-11] Phenytoin is a weak P-glycoprotein substrate in rat-Initial PET studies M Labots, J Verbeek, J Eriksson, EC de Lange, RC Schuit, M Rongen, ... JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 54, S286-S286, 2011 | 3 | 2011 |
Binding characterization of N‐(2‐chloro‐5‐thiomethylphenyl)‐N′‐(3‐[3H] 3methoxy phenyl)‐N′‐methylguanidine ([3H] GMOM), a non‐competitive N‐methyl‐D‐aspartate (NMDA) receptor … A Metaxas, BNM van Berckel, PJ Klein, J Verbeek, EC Nash, ... Pharmacology Research & Perspectives 7 (1), e00458, 2019 | 2 | 2019 |
Parametric methods for dynamic 11C-phenytoin PET studies S Mansor, M Yaqub, R Boellaard, FE Froklage, A De Vries, EDM Bakker, ... Journal of Nuclear Medicine 58 (3), 479-483, 2017 | 2 | 2017 |